20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7194 | CM-272 | Apoptosis , DNA Methyltransferase , Histone Methyltransferase | |
CM-272 is a dual G9a/DNA methyltransferases (DNMTs) inhibitor. | |||
T7022 | PEG300 | Polyethylene glycol 300 | Others |
PEG300 (Polyethylene glycol 300) is a polymer formed from repeating units of ethylene glycol that is water soluble, low immunogenicity, and biocompatible. PEG300 is a neutral polymer with a molecular weight of 300. | |||
TP1554L | HPV16 E7 (86-93) acetate | HPV16 E7 (86-93) acetate(160212-93-1 Free base) | Others |
HPV16 E7 (86-93) acetate is a derived peptide of human leukocyte antigen A2.1 restricted HPV16 E7 with immunogenic property in cervical carcinomas. | |||
T11855 | Lipopolysaccharides | LPS | Others |
Lipopolysaccharides (LPS) is a natural product, an endotoxin derived from the outer leaflet of the outer membrane of Gram-negative bacteria. Lipopolysaccharides are highly immunogenic antigens that enhance the immune res... | |||
T7657L | MOG peptide (35-55) , mouse, rat acetate | Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate,MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base) | Others |
Myelin Oligodendrocyte Glycoprotein (MOG) peptide (35-55) , mouse, rat acetate is a MOG peptide (35-55) derivative. MOG peptide (35-55) is a part of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide and can b... | |||
T15003 | CP-20961 | Others | |
CP-20961 is a synthetic non-immunogenic adjuvant. It induces arthritis. | |||
T27859 | LTX-401 HCl | LTX 401,LTX401,LTX-401 | |
LTX-401 is an immunotherapeutic agent and an oncolytic amino acid derivative with potential immunogenic properties. | |||
T33626 | Nelipepimut-S | NeuVax vaccine,E75 peptide,NeuVax | |
Nelipepimut-S, as an immunogenic peptide from the HER2 protein, is highly expressed in breast cancer. | |||
T35421 | 2'-O-Succinyl-cAMP | ||
2'-O-Monosuccinyladenosine-3',5'-cyclic monophosphate is an immunogenic derivative of cAMP that has been used to generate anti-cAMP antisera and antibodies.1,2 | |||
T38936 | KRAS G13D peptide, 25 mer | KRAS G13D peptide, 25 mer | |
KRAS G13D peptide, a 25-mer sequence, is derived from the KRAS activating oncogene mutation and serves as an immune potentiator. This peptide possesses immunogenic properties and can be utilized for the development of a ... | |||
T82348 | GAGGVGKSAL | ||
GAGGVGKSAL, a wild-type KRAS G12D 10mer peptide, serves as an immunogenic neoantigen in cancer immunotherapy research [1]. | |||
T82352 | GADGVGKSAL | ||
GADGVGKSAL, a mutant KRAS G12D 10mer peptide, serves as an immunogenic neoantigen in cancer immunotherapy research [1]. | |||
T82349 | GAGGVGKSA | ||
GAGGVGKSA, a wild-type KRAS G12D 9mer peptide, serves as an immunogenic neoantigen pivotal for cancer immunotherapy research [1]. | |||
T82353 | GADGVGKSA | ||
GADGVGKSA, a mutant KRAS G12D 9mer peptide, serves as an immunogenic neoantigen for cancer immunotherapy research [1]. | |||
T83135 | Alrefimotide | hTERT (660–689) | |
Alrefimotide, an immunogenic peptide derived from hTERT, possesses the sequence ALFSVLNYERARRPGLLGASVLGLDDIHRA and has applications in cancer immunotherapy research [1]. | |||
T76015 | HPV16 E7 (86-93) (TFA) | ||
HPV16 E7 (86-93) TFA, a peptide derived from HPV16 E7, is restricted by human leukocyte antigen (HLA)-A2.1 and exhibits immunogenic properties in cervical carcinomas [1] [2]. | |||
TP1554 | HPV16 E7 (86-93) | ||
This is amino acids 86 to 93 fragment of the human papilloma virus (HPV) type 16 oncoprotein E7. This HPV16-encoded peptide has very high affinity of binding to the HLA-A*0201 molecule.This immunogenic fragment may be us... | |||
T39110 | MOG (35-55), human | ||
MOG (35-55), human, a constituent of central nervous system myelin, is distinguishable from mMOG (35-55) due to a proline-to-serine substitution at position 42. It possesses immunogenic properties and is partially cross-... | |||
T36996 | MSA-2 dimer | ||
MSA-2 dimer, a selective and orally active non-nucleotide STING agonist with a dissociation constant (Kd) of 145 μM, demonstrates prolonged antitumor and immunogenic activity. It non-covalently binds to STING as a dimer,... | |||
T73544 | MPM-1 | ||
MPM-1, a mimic of marine Eusynstyelamides, serves as an effective anticancer agent. It swiftly induces a necrosis-like death in cancer cells in vitro, facilitates immunogenic cell death, and disrupts autophagy, leading t... |